Drugs / TMI-358
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01093118 | Sep 2009 → Apr 2011 | tinea unguium | Talima Therapeutics, Inc. | Terminated | No outcome recorded Stop: Business |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | TMI-358 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01093118 ↗ |